Evidence map›Paper›PMID 25760618›Full record

ArticleActa crystallographica. Section D, Biological crystallography2015

The structure of the hexameric atrazine chlorohydrolase AtzA.

T S Peat, J Newman, S Balotra, D Lucent, A C Warden, C Scott

Open access · hybridAbstract read
In one paragraph

Article in Acta crystallographica. Section D, Biological crystallography, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. The evolving story of AtzT, a periplasmic binding protein.Acta crystallographica. Section D, Structural biology · 2019
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

T S PeatCSIRO Biomedical Manufacturing, Parkville, Australia.
J NewmanCSIRO Biomedical Manufacturing, Parkville, Australia.
S BalotraResearch School of Chemistry, Australian National University, Canberra, Australia.
D LucentDivision of Engineering and Physics, Wilkes University, Wilkes-Barr, Pennsylvania, USA.
A C WardenCSIRO Land and Water Flagship, Black Mountain, Canberra, Australia.
C ScottCSIRO Biomedical Manufacturing, Parkville, Australia.
CSIRO Manufacturing · AUAustralian National University · AUCSIRO Land and Water · AUWilkes University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atrazine chlorohydrolase (AtzA) was discovered and purified in the early 1990s from soil that had been exposed to the widely used herbicide atrazine. It was subsequently found that this enzyme catalyzes the first and necessary step in the breakdown of atrazine by the soil organism Pseudomonas sp. strain ADP. Although it has taken 20 years, a crystal structure of the full hexameric form of AtzA has now been obtained. AtzA is less well adapted to its physiological role (i.e. atrazine dechlorination) than the alternative metal-dependent atrazine chlorohydrolase (TrzN), with a substrate-binding pocket that is under considerable strain and for which the substrate is a poor fit.

Indexed as

Soil MicrobiologyBacterial ProteinsCrystallography, X-RayHydrolasesProtein Structure, TertiaryPseudomonasatrazine chlorohydrolaseBacterial ProteinsHydrolasesatrazine chlorohydrolase

Identifiers

PMID25760618
PMCPMC4356373
OpenAlexW2131345428

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.